Explore Bio-Techne's Upcoming Investor Conference Presentations
Bio-Techne Announces Upcoming Investor Conferences
Bio-Techne Corporation (NASDAQ: TECH) has recently provided details regarding its participation in multiple investor conferences. These events represent an excellent opportunity for investors to gain insights into the company's innovative products and future directions.
Conference Schedule Details
The following are the key investor conferences where Bio-Techne will present:
UBS Global Healthcare Conference
Bio-Techne will present on November 12. This is one of the premier events for healthcare investment discussions.
Stifel 2024 Healthcare Conference
On November 19, investors will have another chance to hear from Bio-Techne at this influential gathering.
Stephens NASH 2024 Conference
Finally, on November 20, Bio-Techne will wrap up its presentations for the month during this specialized conference focused on liver diseases.
Webcast Availability
Investors interested in viewing the presentations live can access a webcast through Bio-Techne's Investor Relations website. This platform offers a convenient way for attendees to follow along and stay informed on the company's ongoing developments.
About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) has established itself as a leader in the global life sciences sector. The company develops and supplies a wide array of tools and bioactive reagents that support research and diagnostics in the scientific community. Their extensive product lineup plays a crucial role in understanding biological processes and disease progression.
With previous fiscal reports indicating impressive net sales of approximately $1.2 billion and a dedicated workforce of roughly 3,100 employees globally, Bio-Techne is committed to enhancing scientific research capabilities. The company's products are pivotal in drug discovery and facilitating precise clinical diagnostics.
For those who wish to delve deeper into Bio-Techne's portfolio, the company encourages visits to its official website, where comprehensive details about their offerings can be explored. Additionally, Bio-Techne maintains a robust online presence, engaging with audiences across multiple social media platforms.
Contact Information
Those looking to reach out to Bio-Techne can direct inquiries to David Clair, Vice President of Investor Relations & Corporate Development. The company values communication with its investors and stakeholders.
Phone: 612-656-4416
Frequently Asked Questions
What investor conferences will Bio-Techne be attending?
Bio-Techne will be attending the UBS Global Healthcare Conference, Stifel 2024 Healthcare Conference, and the Stephens NASH 2024 Conference.
Who can I contact for more details about Bio-Techne?
David Clair, Vice President of Investor Relations & Corporate Development, is the primary contact for inquiries.
What is the significance of these investor conferences?
These conferences provide stakeholders with valuable insights into Bio-Techne's strategies, innovations, and overall market positioning.
How can I access the live webcasts?
Webcasts of Bio-Techne's presentations will be available on the company’s Investor Relations website.
What does Bio-Techne offer in the life sciences sector?
Bio-Techne provides innovative tools and bioactive reagents for research and clinical diagnostics across various scientific fields.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.